The genetic engineering of organ-donor animals to decrease the risk of human immune system rejection poses ethical and psychological challenges to the long-held boundary between humans and other animal species.
Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication.